Adverse Reactions to Immunotherapy Can Appear After a Year

Clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death […]

» Read more

Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product

An experimental immunotherapy that contains a genetically altered version of herpes simplex virus type 1 (HSV-1) was associated with a […]

» Read more